<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Calcium_disodium_EDTA</id>
	<title>Calcium disodium EDTA - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Calcium_disodium_EDTA"/>
	<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Calcium_disodium_EDTA&amp;action=history"/>
	<updated>2026-04-18T11:01:29Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.38.2</generator>
	<entry>
		<id>https://wikem.org/w/index.php?title=Calcium_disodium_EDTA&amp;diff=389792&amp;oldid=prev</id>
		<title>Danbot: Created Calcium disodium EDTA (CaNa2EDTA) medication page for lead chelation with standard template</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Calcium_disodium_EDTA&amp;diff=389792&amp;oldid=prev"/>
		<updated>2026-03-25T02:59:31Z</updated>

		<summary type="html">&lt;p&gt;Created Calcium disodium EDTA (CaNa2EDTA) medication page for lead chelation with standard template&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;==Administration==&lt;br /&gt;
*Type: Chelating agent&lt;br /&gt;
*Dosage Forms: injection (200 mg/mL)&lt;br /&gt;
*Routes of Administration: IV (preferred), IM (with procaine to reduce pain)&lt;br /&gt;
*Common Trade Names: Calcium Disodium Versenate, CaNa2EDTA&lt;br /&gt;
&lt;br /&gt;
==Adult Dosing==&lt;br /&gt;
===[[Lead poisoning]] (symptomatic or BLL &amp;gt;70 mcg/dL)===&lt;br /&gt;
*1000-1500 mg/m²/day IV as continuous infusion or divided q6-12h&lt;br /&gt;
*Maximum: 3 g/day (or 50 mg/kg/day if using weight-based dosing)&lt;br /&gt;
*Duration: 5 days; may repeat after 2-4 day drug-free interval if needed&lt;br /&gt;
*For [[lead encephalopathy]]: use in combination with [[dimercaprol]] (BAL); start BAL 4 hours before CaNa2EDTA&lt;br /&gt;
&lt;br /&gt;
===IM dosing (if IV not available)===&lt;br /&gt;
*Same dose; mix with 1% procaine to reduce injection pain&lt;br /&gt;
&lt;br /&gt;
==Pediatric Dosing==&lt;br /&gt;
===[[Lead poisoning]] (BLL ≥45 mcg/dL or symptomatic)===&lt;br /&gt;
*1000-1500 mg/m²/day IV as continuous infusion or divided q6-12h&lt;br /&gt;
*Maximum: 50 mg/kg/day&lt;br /&gt;
*Duration: 5 days; may repeat after 2-4 day drug-free interval&lt;br /&gt;
*For [[lead encephalopathy]]: always use with [[dimercaprol]] (BAL); start BAL 4 hours before CaNa2EDTA&lt;br /&gt;
&lt;br /&gt;
==Special Populations==&lt;br /&gt;
===[[Drug pregnancy categories|Pregnancy Rating]]===&lt;br /&gt;
*B&lt;br /&gt;
&lt;br /&gt;
===Lactation risk===&lt;br /&gt;
*Unknown; use caution&lt;br /&gt;
&lt;br /&gt;
===Renal Dosing===&lt;br /&gt;
*Adult: Contraindicated in anuria; reduce dose in renal impairment; monitor renal function closely&lt;br /&gt;
*Pediatric: Same as adult&lt;br /&gt;
&lt;br /&gt;
===Hepatic Dosing===&lt;br /&gt;
*Adult: No specific adjustment&lt;br /&gt;
*Pediatric: No specific adjustment&lt;br /&gt;
&lt;br /&gt;
==Contraindications==&lt;br /&gt;
*Allergy to class/drug&lt;br /&gt;
*Anuria or severe renal disease&lt;br /&gt;
*Hepatorenal syndrome&lt;br /&gt;
*Active [[hepatitis]]&lt;br /&gt;
&lt;br /&gt;
==Adverse Reactions==&lt;br /&gt;
===Serious===&lt;br /&gt;
*Nephrotoxicity (renal tubular necrosis — dose-dependent; monitor BUN/Cr daily)&lt;br /&gt;
*Severe hypocalcemia (if disodium EDTA used instead — ensure CALCIUM disodium EDTA is used)&lt;br /&gt;
*Cardiac arrhythmias (from electrolyte shifts)&lt;br /&gt;
*Bone marrow suppression&lt;br /&gt;
&lt;br /&gt;
===Common===&lt;br /&gt;
*Nausea, vomiting&lt;br /&gt;
*Injection site pain (IM)&lt;br /&gt;
*Fever, chills&lt;br /&gt;
*Fatigue, malaise&lt;br /&gt;
*Transient hypotension&lt;br /&gt;
*Zinc depletion (with prolonged courses)&lt;br /&gt;
&lt;br /&gt;
==Pharmacology==&lt;br /&gt;
*Half-life: 20-60 minutes (IV)&lt;br /&gt;
*Metabolism: Not metabolized&lt;br /&gt;
*Excretion: Renal (&amp;gt;95% excreted as chelate complex within 24 hours)&lt;br /&gt;
&lt;br /&gt;
==Mechanism of Action==&lt;br /&gt;
*Forms stable, water-soluble chelate complex with divalent and trivalent metals (especially lead)&lt;br /&gt;
*Chelate complex is excreted renally, reducing body lead burden&lt;br /&gt;
*Does not cross the blood-brain barrier significantly (which is why BAL is used concurrently for encephalopathy)&lt;br /&gt;
&lt;br /&gt;
==Comments==&lt;br /&gt;
*CRITICAL: Ensure CALCIUM disodium EDTA (CaNa2EDTA) is used — NOT disodium EDTA (Na2EDTA), which causes fatal hypocalcemia&lt;br /&gt;
*For lead encephalopathy, always start [[dimercaprol]] (BAL) 4 hours before CaNa2EDTA to prevent redistribution of lead into the brain&lt;br /&gt;
*Monitor serum BUN, creatinine, electrolytes, CBC, and urinalysis daily during treatment&lt;br /&gt;
*Adequate hydration is essential but avoid overhydration in encephalopathic patients (risk of cerebral edema)&lt;br /&gt;
*A &amp;quot;provocation test&amp;quot; (single dose followed by urine lead measurement) is no longer recommended&lt;br /&gt;
*Consider [[succimer]] (DMSA) as oral alternative for BLL 45-69 mcg/dL without encephalopathy&lt;br /&gt;
&lt;br /&gt;
==Indications by Condition==&lt;br /&gt;
''The following table is automatically generated from disease/condition pages across WikEM.''&lt;br /&gt;
{{#ask:[[Has DrugName::Calcium disodium EDTA]]&lt;br /&gt;
|?Has Indication=Indication&lt;br /&gt;
|?Has Dose=Dose&lt;br /&gt;
|?Has Context=Context&lt;br /&gt;
|?Has Route=Route&lt;br /&gt;
|?Has Population=Population&lt;br /&gt;
|format=table&lt;br /&gt;
|headers=plain&lt;br /&gt;
|mainlabel=-&lt;br /&gt;
|sort=Has Indication&lt;br /&gt;
|limit=50&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[Lead poisoning]]&lt;br /&gt;
*[[Succimer]]&lt;br /&gt;
*[[Dimercaprol]]&lt;br /&gt;
*[[Deferoxamine]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Pharmacology]]&lt;/div&gt;</summary>
		<author><name>Danbot</name></author>
	</entry>
</feed>